Tier 3 · Filer Universe

Foghorn Therapeutics Inc.

FHTX · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$5.10
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001822462
Liquidity rank
#3907
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$30.91M2025-12-310001628280-26-016814
Annual diluted EPS-1.182025-12-310001628280-26-016814
Quarterly revenue$3.27M2026-03-310001628280-26-031671
Quarterly diluted EPS-0.292026-03-310001628280-26-031671

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.054Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer

Provenance